The new clinical guidelines from the American College of Gastroenterology advise people with obesity, hepatitis C or B virus infections, or a history of gastric bypass to avoid alcohol to prevent alcohol-associated liver disease (ALD). Alcohol use disorder (AUD) should be treated with behavioral interventions and pharmacotherapy. The rising incidence of alcohol use has led to rapid growth in ALD-related healthcare burdens. Policymakers need to reduce alcohol use and focus on at-risk populations. Physicians should provide evidence-based guidelines and consider the impacts of alcohol regulations and marketing. The typical patient for liver disease and AUD is now younger and needs a different approach to treatment.
Source link